“…In particular, the newer antipsychotics, although better tolerated than previous generations of drugs, have a high incidence rate of metabolic syndrome. This topic has already been extensively studied, including in this journal (Ijaz et al ., 2018; Akinola et al ., 2023; De Carlo et al ., 2023; Osimo et al ., 2023). The article in this issue presents data that further contributes to our understanding of the phenomenon, not least because it uses a strict definition of metabolic syndrome (Abdel Aziz et al ., 2024).…”